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reduces atherosclerosis risk factors in rats
fed a high-fat diet
Jiqu Xu1,2, Wei Yang3, Qianchun Deng1,2, Qingde Huang1,2, Jin’e Yang1,2 and Fenghong Huang1,2*Abstract
Background: Atherosclerosis is a major manifestation of the pathophysiology underlying cardiovascular disease.
Flaxseed oil (FO) and α-lipoic acid (LA) have been reported to exert potential benefit to cardiovascular system. This
study tried to assess the effect of supplement of FO and LA combination on the atherosclerosis risk factors in rats
fed a high-fat diet.
Methods: LA was dissolved in flaxseed oil to a final concentration of 8 g/kg (FO+LA) when used. The rodent diet
contained 20% fat. One-fifth of the fat was soybean oil and the others were lard (HFD group), or 75% lard and 25%
FO+LA (L-FO+LA group), or 50% lard and 50% FO+LA (M-FO+LA group), or FO+LA (H-FO+LA group). Animals were
fed for 10 weeks and then killed for blood collection.
Results: Supplement of FO and LA combination significantly enhanced plasma antioxidant defense capacities, as
evaluated by the marked increase in the activities of SOD, CAT and GPx as well as the level of GSH, and the
significant reduction in lipid peroxidation. Simultaneous intake of FO and LA also reduced plasma TG, TC and
LDL-C contents and elevated the ratio of HDL-C/LDL-C. Besides, in parallel with the increase of FO and
LA combination, plasma IL-6 and CRP levels were remarkably reduced.
Conclusion: Supplement of FO and LA combination may contribute to prevent atherogenesis by improving plasma
oxidative stress, lipid profile and inflammation.
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Cardiovascular disease (CVD) is widely recognized as the
leading cause of premature death and a major cause of
disability in most developed and developing countries.
Atherosclerosis, a manifestation of the pathophysiology
underlying CVD, constitutes the single most important
contributor to this growing burden of this disease. Recent
studies suggest that oxidant stress [1], lipid abnormalities
[2] and chronic inflammation [3] play important roles in
the etiology of atherosclerosis and subsequent CVD.* Correspondence: fhhuang@foxmail.com
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reproduction in any medium, provided the orFlaxseed oil (FO) is the main component of the flax-
seed and one of the world's most important vegetable
sources of α-linolenic acid (LNA, 18:3n-3). As a nutri-
tionally essential polyunsaturated fatty acid (PUFA), LNA
can act as the precursor of longer chain n-3 PUFA (EPA
and DHA) or compete with linoleic acid or direct inter-
action with ion channels and nuclear receptors, and thus
may exert various biological functions in the human
body, such as accelerating brain growth in preterm and
neonatesand, antiarrhythmic functions and neuroprotec-
tive functions [4]. In addition, LNA is also reported to
have beneficial effects on blood lipid profiles [4-7] and
inflammation [4,8,9], which may responsible for the pro-
tection against CVD bestowed by FO. However, on the
other hand, since LNA is highly susceptible to oxidation,
FO addition leads to a significantly higher tendency
toward plasma lipid peroxidation [10,11], which mayThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cular system.
α-lipoic acid (LA), also referred to as thioctic acid, is a
disulfide compound that is found naturally in mito-
chondria as the coenzyme for pyruvate dehydrogenase
and α-ketoglutarate thus serves a critical role in mito-
chondrial energy metabolism. Although orally supplied
LA may not be used as a metabolic cofactor, there are
a unique set of biochemical activities with potential phar-
macotherapeutic value against a host of pathophysiologic
insults [12]. For example, LA has gained considerable
attention as an excellent antioxidant to reduce oxidative
stress [13-15]. Further, LA is fat- and water-soluble,
which makes it effective against a broader range of free
radicals. Early studies have shown the capacity of LA to
decrease plasma lipids in rats [16-18]. Besides, LA also
exhibits an anti-inflammatory activity in clinical trial
[19]. These mechanisms make LA possess the potential
abilities for antiatherogenesis.
To our knowledge, the effects of a simultaneous intake
of FO and LA on cardiovascular system have not been
investigated. Therefore, the objectives of this study were
to determine that whether FO and LA combination can




Commercial deodorized lard was purchased from a local
supermarket. The flaxseed oil was obtained from
Caoyuankangshen Food Co., Ltd., and its fatty acid com-
positions were listed in Table 1. LA was purchased from
Sigma-Aldrich (St. Louis, MO, USA) and was dissolved
in flaxseed oil to a final concentration of 8 g/kg (FO+LA)
when used.
Animals and diets
The experiment was conducted with 40 male Sprague–
Dawley rats (initially weighing 150–170 g). The animals
were housed individually and maintained at a controlled
ambient temperature (24 ± 1 °C) under diurnal conditions
(light–dark: 08:00–20:00) with access to laboratory chow
and tap water ad libitum. After 1 week of acclimatization,
rats were randomly divided into a high-fat diet (HFD)
group and three experimental groups (n =10 per group).Table 1 Fatty acid compositions of flaxseed oil
Fatty acid Composition (wt.%)
Palmitic acid (C16:0) 6.1
Stearic acid (C18:0) 3.7
Oleic acid (C18:1) 22.4
Linoleic acid (C18:2) 14.9
Linolenic acid (C18:3) 52.9All animals were fed purified experimental diets which
contained 35% maize starch, 20% casein, 15% sucrose, 5%
cellulose, 3.5% mineral mixture (AIN-93M), 1% vitamin
mixture (AIN-93M), 0.3% DL-methionine, 0.2% choline
bitartrate and 20% fat. One-fifth of the fat in the diet of
each group was soybean oil and the others were lard
(HFD group), or 75% lard and 25% FO+LA (L-FO+LA
group), or 50% lard and 50% FO+LA (M-FO+LA group),
or FO+LA (H-FO+LA group). Every week, all ingredients
for the purified diets were mixed, formed into a dough
with purified water, rolled into pellets, sealed in air-tight
plastic bags under nitrogen gas and stored at −80°C until
use. The food in the animal cages was shaded from light
and changed every day. The animals were cared for in
accordance with the Guiding Principles in the Care and
Use of Animals. The experiment was approved by the
local animal care committee.
Blood processing
After 10 weeks of feeding, animals, fasted for 16 hours,
were killed under anaesthesia, blood was collected in the
presence of sodium heparin from the heart immediately.
Blood samples were centrifuged at 1500 g for 10 min at
4°C and the plasma was stored at −80°C until analysis.
Plasma lipids analysis
The plasma triglyeride (TG), total cholesterol (TC), low-
density lipoprotein cholesterol (LDL-C) and high-density
lipoprotein cholesterol (HDL-C) levels were measured
using commercial enzymatic kits (Zhongsheng Beikong
Biotech Company, China).
Assay of liver antioxidant capacity and lipid peroxidation
Superoxide dismutases (SOD) activity was measured
according to the method of Kono [20]. Catalase (CAT)
activity was estimated basing on the method of Goth
[21]. Glutathione peroxidase (GPx) activity was measured
by the method of Sazuka [22]. The glutathione (GSH)
content was determined by the method of Moron [23].
The total antioxidant capability (T-AOC) was assayed
with commercial kits (Nanjing Jiancheng Bioengineering
Institute, China).Thiobarbituric acid reactive substances
(TBARS) level was estimated by the method of Buege
[24]. The detection procedure of these enzymes activities
has been described in detail in our previous report [25].
Assay of protein concentration
The protein concentration was determined by the
method of Lowry [26] with bovine serum albumin as the
standard.
Assay of plasma inflammatory markers
The C-reactive protein (CRP) and interleukin 6 (IL-6)
levels in plasma were measured with the use of
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San Diego, CA) and rat IL-6 ELISA kit (eBioscience San
Diego, CA), respectively. All the procedures and condi-
tions were consistent with the instructions of these kits.
Statistical analyses
Values are presented as mean ± SEM (standard error of
the mean). The data were analyzed by one-way ANOVA,
followed by the Fisher PLSD post hoc test if the overall
differences were significant (p< 0.05). All statistical ana-
lyses were performed using SPSS 13.0 statistical software
(SPSS Inc., Chicago, IL) and a difference was considered
significant when p < 0.05.Groups

































































Figure 1 Effects of FO and LA combination on the activities of antiox
contents of TBARS in plasma of rats fed a high-fat diet. HFD: high-fat d
FO and LA combination groups. Bars represent the mean ± SD from 10 an
group.Results
Plasma antioxidative capacity and lipid peroxidation
As shown in Figure 1, animals in M- and H- FO+LA
groups revealed significantly higher plasma antioxidant
enzymes SOD, CAT and GPx activities than their coun-
terparts in HFD group. Administration of L-, M- and
H- FO+LA for 10 weeks significantly augmented the
GSH levels in plasma when compared to rats treated
with HFD. As the overall antioxidative capacity, plasma
T-AOC in all three FO+LA groups was markedly higher
than that in HFD group. Moreover, when plasma TBARS
were evaluated as the marker of lipid peroxidation,
there were significant decline in the levels of plasmaGroups






















































idant enzymes (SOD, CAT and GPx), the levels of GSH, T-AOC and
iet group; L-. M- and H- FO + LA: low, middle and high contents of
imals in each group. * p < 0.05 and ** p < 0.01 compared to the HFD
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with those in HFD group.Plasma lipids
The effects of FO+LA on the levels of plasma lipids are
shown in Figure 2. Animals in M- and H-FO+LA groups
exhibited significantly lower plasma TG and TC levels
than that in HFD group. There were no marked differ-
ences in the level of plasma HDL-C in all groups, while
rats in all FO+LA groups showed significantly lower
LDL-C levels than that in HFD group. As results, M- and
H-FO+LA groups had significantly higher ratios of HDL
to LDL cholesterol than HFD group.Groups























































Figure 2 Effects of FO and LA combination on various plasma lipid p
HDL-C/LDL-C of rats fed a high-fat diet. HFD: high-fat diet group; L-. M-
combination groups. Bars represent the mean ± SD from 10 animals in eacPlasma inflammatory
As can be seen in Figure 3, there were significantly
decline in the plasma levels of IL-6 and CRP in all three
FO+LA groups when compared with those in HFD
group.
Discussion
FO has gained more and more attention in many areas
recently primarily because it is one of the richest sources
of LNA. As the plant precursor of EPA and DHA, ALA
may produce significant cardiovascular benefits which
have been proved by some clinical trials, epidemiological
investigations and experimental studies [27]. LA is a
potent natural antioxidant and represents a possibleGroups




































arameters (TG, TC, LDL-C and HDL-C) and on the ratios of plasma
and H- FO + LA: low, middle and high contents of FO and LA
h group. * p < 0.05 and ** p < 0.01 compared to the HFD group.
Groups


































Figure 3 Effects of FO and LA combination on the level of IL-6 and CRP in plasma of rats fed a high-fat diet. HFD: high-fat diet group; L-.
M- and H- FO + LA: low, middle and high contents of FO and LA combination groups. Bars represent the mean ± SD from 10 animals in each
group. ** p < 0.01 compared to the HFD group.
Xu et al. Lipids in Health and Disease 2012, 11:148 Page 5 of 7
http://www.lipidworld.com/content/11/1/148protective agent against risk factors of CVD [28]. In
this report, we examined the effect of FO and LA
combination on atherosclerosis risk factors in rats fed
a high-fat diet.
The imbalance between cellular production of free
radicals and the antioxidant defense is referred to as oxi-
dative stress. The relative excessive production of free
radicals can attack all types of biomolecules, which may
affect oxidation of low density lipoproteins and lead to
the destruction of cellular components and thus initiates
the processes of atherogenesis. Growing evidence indi-
cates that oxidative stress is the pivotal pathogenetic fac-
tor and unifying mechanism for atherosclerosis and
other cardiovascular diseases [29]. For example, free
radicals are key mediators of various signaling pathways
which underlie vascular inflammation in atherogenesis
[30]. However, an efficient antioxidant defense mechan-
ism (enzymatic and non-enzymatic) is able to counteract
the deleterious effects of oxidative stress. The primary
antioxidant enzymes in mammals include SOD which
converts superoxide to hydrogen peroxide, GPx and
CAT which are responsible for converting hydrogen per-
oxide to water [31]. GSH is a very important non-
enzymatic antioxidant which can react directly with free
radicals or act as an electron donor in the reduction of
peroxides catalyzed by GPx [32]. In the present study,
FO and LA combination markedly increased the plasma
activities of these antioxidant enzymes (SOD, CAT and
GPx) as well as GSH level, which resulted in pro-
nounced enhancement of plasma T-AOC. As a conse-
quence, plasma lipid peroxidation levels significantly
declined with the supplement of FO and LA combin-
ation. However, FO itself is hardly thought to have any
antioxidative activity and further, it may cause lipid per-
oxidation because of its susceptibility to oxidation
[10,11]. Therefore, LA should impart the entire antioxi-
dative potency in this experiment. In fact, LA has been
proved to be a potent multifunctional biological antioxi-
dant. It can reduce oxidative stress by scavenging freeradicals, chelating transition metals, increasing intracel-
lular GSH and the redox regeneration of other antioxi-
dants such as vitamins C and E [13-15,33,34]. In
addition, LA also decreases oxidative stress by restoring
enzymatic antioxidant system in blood in different status
[34,35].
It is well known that hyperlipidemia is a highly predis-
posing condition for arteriosclerosis and other cardio-
vascular disease. A large body of evidence has been
presented showing that high-fat diet rich in saturated
fatty acid results in hyperlipidemia. In the present study,
FO and LA combination decreased the plasma TG, TC
and LDL-C levels, and both of them contributed to these
beneficial changes. LNA and LA have both been
reported to suppress the expression and activities of
many hepatic fatty acid syntheses such as fatty acid syn-
thase (FAS), malic enzyme and glucose 6-phosphate de-
hydrogenase [36-38], and hence decrease fatty acid
synthesis in liver. On the other hand, LNA sharply
enhances hepatic peroxisomal and mitochondrial fatty
acid oxidation rate by increasing the expression and ac-
tivities of a series of fatty acid oxidation enzymes
[37,39], and LA also shows the similar action on indu-
cing fatty acid oxidation [18]. In addition, FO has been
shown to have hypocholesterolaemic effect, which might
result from increases of hepatic LDL-receptor expression
and cholesterol catabolism/output [7]. Administration of
LA can likewise reduce the elevated plasma TC and
LDL-C induced by high-fat diet by downregulating the
expression of genes involved in cholesterol synthesis in
liver [18]. Although simultaneous intake of FO and LA
did not markedly affect plasma HDL-C level in the
present study, the significant increase in the ratio of
HDL to LDL cholesterol still meant that the combin-
ation of FO and LA had a marked protective effect with
respect to atherosclerosis.
Based on strong experimental and clinical evidence,
the general consensus is that inflammation plays a cen-
tral role in both initiation and progression of the
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risk factors such as oxidized LDL and infectious agents
can trigger the production of proinflammatory cytokines
which are central mediators of inflammation associated
with atherogenesis. As two of the most important proin-
flammatory cytokines, IL-6 and CRP are associated with
CVD and served as inflammatory markers for prediction
of atherosclerotic risk [43-45]. In the present study, sup-
plement of FO and LA remarkably reduced the plasma
levels of both IL-6 and CRP, which meant that combin-
ation of FO and LA has an ability to improve inflamma-
tion status. Supporting our results, intakes of dietary FO
or LA have been shown to elicit antiinflammatory effects
by inhibiting inflammatory cytokine production. For
example, FO can suppress the expression of inflammatory
cytokine such as IL-6, IL-1, CRP and TNF-α via a reduc-
tion in NF-κB induced gene expression and/or an activa-
tion of PPAR-γ [4,8,46]. Similarly, LA has also been
demonstrated to inhibit NF-κB activation independent of
its antioxidant function [47,48] and thus reduce circulat-
ing levels of inflammatory markers [19].
In summary, the combination of FO and LA is effect-
ive in amelioration of oxidative stress, lipid profile and
inflammation of plasma in rats fed a high-fat diet. These
results suggested that supplement of FO and LA com-
bination might contribute to prevent atherogenesis and
then decrease the incidence of CVD.
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